Takeda Agrees To $13.6M Settlement Of False Claims Allegations Of Improper Payments To Physicians
The United States Department of Justice announced on May 14, 2026 that Takeda Pharmaceuticals, U.S.A. Inc. has agreed to pay $13,670,921 to resolve allegations that it knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to healthcare[...]

